Reviva Pharmaceuticals (RVPHW) Stock Price, News & Analysis

Company Overview

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage specialty pharmaceutical company committed to developing novel therapies for dermatologic and ophthalmic conditions with high unmet medical need. The company leverages proprietary formulation and drug‐delivery technologies to advance product candidates through preclinical and clinical development, aiming to enhance solubility, stability and bioavailability in topical and ocular applications.

Reviva’s pipeline comprises multiple investigational candidates at various stages. Its lead program, RVI-001, is a topical solution designed to treat common plantar warts and is advancing toward late‐stage clinical testing. Additional programs target inflammation‐driven skin disorders and ocular surface diseases, reflecting the company’s strategic focus on conditions with limited approved therapies. Reviva maintains strategic collaborations with contract research and manufacturing organizations to support formulation optimization and scalable production.

Headquartered in Palm Beach County, Florida, Reviva Pharmaceuticals conducts its research and development activities primarily in the United States, with clinical trials spanning sites across North America. Since its founding, the company has assembled a team of experts in dermatology, ophthalmology, formulation science and regulatory affairs. Reviva’s common shares trade on the NASDAQ Capital Market under the ticker RVPH, while its warrants trade under the symbol RVPHW.

Key Stats

• Today's Range: $0.0030 to $0.0050
• 50-Day Range: $0.00 to $0.04
• 52-Week Range: $0.00 to $0.18
• Volume: 251,039 shs
• Average Volume: 86,037 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:RVPHW
• CIK: 1742927
• Web: revivapharma.com
• Phone: 408-501-8881
• Fax: N/A
• Employees: 5
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A